(Q40044972)

16 September 2017

title

Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in Mozambique (English)

1 reference

16 September 2017

0 references

F Maldonado

1

1 reference

16 September 2017

M Biot

2

1 reference

16 September 2017

F Roman

3

1 reference

16 September 2017

C Masquelier

4

1 reference

16 September 2017

M Anapenge

5

1 reference

16 September 2017

R Bastos

6

1 reference

16 September 2017

H C Chuquela

7

1 reference

16 September 2017

V Arendt

8

1 reference

16 September 2017

J C Schmit

9

1 reference

16 September 2017

R Zachariah

10

1 reference

16 September 2017

publication date

18 September 2008

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

16 September 2017

published in

1 reference

16 September 2017

volume

103

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

607-612

1 reference

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

HIV-1 viral load blips are of limited clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

HIV viral load monitoring in resource-limited regions: optional or necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Does tuberculosis increase HIV load?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.07.014

10.1016/J.TRSTMH.2008.07.014

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference